Emerging Treatment Options for Myelofibrosis: Focus on Anemia.
Journal Information
Full Title: Ther Clin Risk Manag
Abbreviation: Ther Clin Risk Manag
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Health Care Sciences & Services
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Dr Douglas Tremblay reports grants, personal fees from CTI Biopharma, grants from Astellas Pharma, grants from Gilead, personal fees from Novartis, personal fees from AbbVie, personal fees from Sierra Oncology, personal fees from GSK, personal fees from Cogent Biosciences, outside the submitted work. The authors report no other conflicts of interest in this work."
"Disclosure: Dr Douglas Tremblay reports grants, personal fees from CTI Biopharma, grants from Astellas Pharma, grants from Gilead, personal fees from Novartis, personal fees from AbbVie, personal fees from Sierra Oncology, personal fees from GSK, personal fees from Cogent Biosciences, outside the submitted work. The authors report no other conflicts of interest in this work."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025